AstraZeneca stock dips as HSBC downgrades stock on ’tough path ahead’

AstraZeneca stock dips as HSBC downgrades stock on ’tough path ahead’

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.